OGT-mediated O-GlcNAcylation regulates macrophage polarization in heart failure via targeting IRF1

Guoqiang Jing1, Yuhong Ma2

  • 1Department of Cardiovascular Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010050, China.

PubMed

Insights

Silencing O-linked N-acetylglucosamine (O-GlcNAcylation) enzyme OGT shifts macrophages to an anti-inflammatory state, alleviating heart failure (HF). This suggests O-GlcNAcylation is a potential therapeutic target for HF.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Medicine

Background:

  • Heart failure (HF) is a global health concern with high mortality.
  • Macrophage inflammation significantly contributes to HF pathogenesis.
  • O-GlcNAcylation, a post-translational modification, influences various cellular processes.

Purpose of the Study:

  • To investigate the role of O-GlcNAcylation in heart failure.
  • To determine the impact of O-GlcNAcylation on macrophage polarization in HF.

Main Methods:

  • Utilized lipopolysaccharide (LPS) to induce pro-inflammatory macrophages in Raw264.7 cells.
  • Generated HF mouse models via transverse aortic constriction (TAC).
  • Assessed macrophage polarization using qPCR and flow cytometry after OGT knockdown or IRF1 overexpression; analyzed mechanisms via bioinformatics, co-IP, IP, and western blotting.

Main Results:

  • Elevated O-GlcNAcylation and OGT levels were observed in LPS-treated cells.
  • OGT knockdown inhibited pro-inflammatory and promoted anti-inflammatory macrophage polarization.
  • OGT silencing alleviated TAC-induced cardiac dysfunction and fibrosis by suppressing IRF1 O-GlcNAcylation at Ser283.

Conclusions:

  • OGT silencing promotes a shift in macrophage polarization towards an anti-inflammatory phenotype, thereby ameliorating HF.
  • This beneficial effect is mediated through the O-GlcNAcylation of IRF1.
  • O-GlcNAcylation emerges as a promising therapeutic strategy for heart failure treatment.
Abstract